NCCN endorses PSA testing in absence of better alternatives

Manag Care. 2014 May;23(5):39-41.
No abstract available

MeSH terms

  • Advisory Committees
  • Aged
  • Biopsy
  • Early Detection of Cancer
  • Evidence-Based Medicine
  • False Positive Reactions
  • Humans
  • Insurance Coverage / economics*
  • Insurance, Health / economics*
  • Male
  • Medicare / economics
  • Middle Aged
  • Patient Protection and Affordable Care Act / economics
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / blood*
  • Societies, Medical
  • United States

Substances

  • Prostate-Specific Antigen